Literature DB >> 15113786

Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration.

Matthew L Maciejewski1, Charles Maynard.   

Abstract

OBJECTIVE: -The purpose of this study was to calculate the total number of inpatient hospitalizations, outpatient clinic visits, and total direct health care costs associated with veterans with diabetes receiving care in Veterans Administration (VA) facilities. RESEARCH DESIGN AND METHODS-The number of inpatient hospitalizations is tracked for years 1994-1998, and outpatient clinic visits are tracked for years 1997 and 1998. Trends in utilization across different age and racial groups, as well as total direct inpatient and outpatient costs for 1998, are presented.
RESULTS: -Between 1994 and 1998, hospitalization rates decreased from 1.68 to 1.61. The average number of outpatient visits was 4.5 in 1997 and 4.6 in 1998. VA incurred $214.8 million in outpatient expenditures and $1.45 billion in inpatient expenditures for veterans with diabetes receiving VA care.
CONCLUSIONS: -Health care delivery systems and payors track the cost and utilization of services by specific patient groups to support disease management, quality improvement, external reporting, and cost containment. Tracking the utilization and cost of diabetes care is necessary to understand the financial impact of diabetes on health care systems and the overall burden of diabetes on individuals.

Entities:  

Mesh:

Year:  2004        PMID: 15113786     DOI: 10.2337/diacare.27.suppl_2.b69

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Effect of Veterans Administration use on indicators of diabetes care in a national sample of veterans.

Authors:  Cheryl P Lynch; Joni L Strom; Leonard E Egede
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

2.  Hospital admission rates for a racially diverse low-income cohort of patients with diabetes: the Urban Diabetes Study.

Authors:  Jessica M Robbins; David A Webb
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

3.  Integrating Diabetes Guidelines into a Telehealth Screening Tool.

Authors:  Kelly Gervera; Barbara Ann Graves
Journal:  Perspect Health Inf Manag       Date:  2015-07-01

Review 4.  Obesity and the US military family.

Authors:  Marian Tanofsky-Kraff; Tracy Sbrocco; Kelly R Theim; L Adelyn Cohen; Eleanor R Mackey; Eric Stice; Jennifer L Henderson; Sarah J McCreight; Edny J Bryant; Mark B Stephens
Journal:  Obesity (Silver Spring)       Date:  2013-09-05       Impact factor: 5.002

Review 5.  Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.

Authors:  Kenneth Maiese; Simona Daniela Morhan; Zhao Zhong Chong
Journal:  Curr Neurovasc Res       Date:  2007-02       Impact factor: 1.990

6.  Web-based telemedicine for management of type 2 diabetes through glucose uploads: a randomized controlled trial.

Authors:  Peiru Zhou; Lingli Xu; Xueyan Liu; Jiewei Huang; Wanping Xu; Weiju Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

7.  A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US.

Authors:  Sandra L Tunis
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 8.  Mechanistic insights into diabetes mellitus and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 9.  Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li; Yan Chen Shang
Journal:  Prog Neurobiol       Date:  2008-03-04       Impact factor: 11.685

10.  Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial.

Authors:  Roslyn A Stone; R Harsha Rao; Mary Ann Sevick; Chunrong Cheng; Linda J Hough; David S Macpherson; Carol M Franko; Rebecca A Anglin; D Scott Obrosky; Frederick R Derubertis
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.